Skip to main content
  • Loading metrics

The spread of cat-transmitted sporotrichosis due to Sporothrix brasiliensis in Brazil towards the Northeast region

  • Aurélio de Oliveira Bento,

    Roles Investigation, Writing – original draft

    Affiliation Laboratório de Micologia Médica e Molecular, Departamento de Análises Clínicas e Toxicológicas, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brasil

  • Alexandre Soares de Sena Costa,

    Roles Investigation

    Affiliation Laboratório de Micologia Médica e Molecular, Departamento de Análises Clínicas e Toxicológicas, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brasil

  • Soraia Lopes Lima,

    Roles Investigation

    Affiliation Laboratório Especial de Micologia, Disciplina de Infectologia, Universidade Federal de São Paulo, São Paulo, Brasil

  • Manoella do Monte Alves,

    Roles Investigation

    Affiliation Departamento de Infectologia, Instituto de Medicina Tropical, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brasil

  • Analy Salles de Azevedo Melo,

    Roles Formal analysis, Resources, Supervision, Writing – original draft

    Affiliation Laboratório Especial de Micologia, Disciplina de Infectologia, Universidade Federal de São Paulo, São Paulo, Brasil

  • Anderson Messias Rodrigues,

    Roles Formal analysis, Resources, Supervision, Writing – original draft

    Affiliation Laboratório de Patógenos Fúngicos Emergentes, Divisão de Biologia Celular, Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brasil

  • Walicyranison Plinio da Silva-Rocha,

    Roles Conceptualization, Investigation, Supervision, Writing – original draft

    Affiliation Laboratório de Micologia Clínica, Departamento de Ciências Farmacêuticas, Universidade Federal da Paraíba, Brazil

  • Eveline Pipolo Milan,

    Roles Conceptualization, Formal analysis, Supervision, Writing – original draft

    Affiliation Departamento de Infectologia, Instituto de Medicina Tropical, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brasil

  • Guilherme Maranhão Chaves

    Roles Conceptualization, Formal analysis, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing

    Affiliation Laboratório de Micologia Médica e Molecular, Departamento de Análises Clínicas e Toxicológicas, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brasil



Sporotrichosis is a worldwide subcutaneous mycosis caused by Sporothrix spp. In the past, this infection was associated with armadillo hunting, horticulturists, miners, and gardeners, being considered an implantation mycosis acquired by plant debris injury. Nevertheless, since the late nineties, it has been considered a zoonotic disease in Brazil. Here we report a case series of 121 patients with cat-transmitted sporotrichosis seen in Northeast Brazil.

Methodology/Principal findings

Patient’s demographic, clinical data, and length of treatment were recorded. In addition, a mycological examination and further PCR confirmation of species identification were performed. One hundred and twenty two patients were diagnosed with subcutaneous sporotrichosis from October 2016 to December 2019, while PCR revealed that 71 of them were due to S. brasiliensis. The majority of the individuals were female (n = 86; 70.5%). Patient’s age ranged from 5 to 87 years old. The clinical forms found were lymphocutaneous (58.2%) and fixed cutaneous (39.4%). Interestingly, 115 patients reported previous contact with cats diagnosed with sporotrichosis. Patients were successfully treated with itraconazole and potassium iodide.


Our study adds important contributions for the investigation of the spread of cat-transmitted subcutaneous sporotrichosis in Brazil, specifically towards the Northeast region of a continental-size country. It will also help clinicians to be aware of the existence and importance to accurately diagnose sporotrichosis and treat patients with this infectious disease in the lowest income region of Brazil.

Author summary

Sporotrichosis is an infectious disease caused by fungi belonging to Sporothrix species. These microorganisms can be found in nature, specifically in the soil and decomposing wood. In the past, sporotrichosis was known as a “rose gardener’s disease”. It is still commonly acquired through injuries with plant debris in most countries around the world. However, a remarkable host shift has happened, allowing Sporothrix to survive in feline hosts (domestic cats) in Brazil. Therefore, the novel discovered fungal species was named Sporothrix brasiliensis. This fungus can grow at a cat´s body temperature (approximately 39°C) and may be found on their claws, blood, and saliva. Because these animals usually bite and scratch each other and their owners, an alternative route of transmission emerged in Rio de Janeiro, Brazil, in the late nineties. Since then, the disease has become an epidemic, and here we demonstrated that it is spreading towards the Northeast region of the country (2,860 km away from Rio de Janeiro). One hundred and twenty one patients were diagnosed with cat-transmitted sporotrichosis, mainly women who work as cleaners or house cleaners and housewives. Nevertheless, all the patients were successfully treated mainly with an antifungal drug called itraconazole.


Sporotrichosis is the most frequent subcutaneous fungal infection that affects both genders without preference of race and age. It has a worldwide distribution, mainly in tropical and subtropical areas, including Africa, Asia, and South America [1]. This infection, which presents a subacute or chronic course, is described as an implantation mycosis by some authors [1,2]. Sporotrichosis has a traditional subcutaneous clinical presentation, known as ascending nodular lymphangitis, palpable gummy lesions that may ulcerate and fistulize, draining a purulent discharge [14]. Nevertheless, sporotrichosis may involve other body sites, including the eyes, muscles, fascia, pulmonary and meningeal sites, besides causing osteoarticular and disseminated diseases [57].

Classically the infection is established after traumatic inoculation into the skin with plant debris, thorns, and straw (sapronotic route) [8]. However, from the early 2000s, this infection has also been associated with animal scratches and bites, mainly felines [2]. In this case, sporotrichosis is considered a zoonotic infection due to the animal to human transmission [9], which is the main route responsible for outbreaks in endemic areas [10].

Sporotrichosis is historically associated with the thermally dimorphic fungus Sporothrix schenckii [11]. However, since 2007, Marimon and colleagues, based on phenotypic and genotypic analyses, proposed four new species: S. globosa, S. brasiliensis, S. mexicana, and S. luriei, formerly S. schenckii var. luriei [12]. These species (except S. mexicana) are currently usually reported as the “pathogenic clade”, whereas the remaining species are placed within an “environmental clade”, including less frequent agents of infections which present mid-to-low pathogenic potential to mammals, such as the S. pallida complex (S. chilensis, S. mexicana, S. humicola, and S. pallida) and the S. stenoceras complex [1315].

In recent years the increased incidence of cat-transmitted sporotrichosis in Brazil has been largely described for quite a few states [9]. In Rio de Janeiro state, the infection is considered an urban epidemic, with more than 5,000 cases of diagnosed zoonotic sporotrichosis in the last 17 years [16]. Besides Rio de Janeiro, which may be considered the most heavily affected state, other studies conducted within different states such as Minas Gerais, Sao Paulo, Parana, Santa Catarina and Rio Grande do Sul have described cases of zoonotic sporotrichosis in the South and Southeast Brazil [17].

The presence of infected felines in densely populated urban areas precedes human infection, and it is also associated with the increased number of cases. As cat transmission to humans is the most common form of zoonotic sporotrichosis, veterinarians, technicians, and cat owners have been considered populations at risk of infection. In this scenario, zoonotic sporotrichosis is considered an important public health problem [9,18].

The epidemiology of cat-transmitted sporotrichosis is poorly investigated in the Northeast Brazil. There are only a few studies published in the literature describing feline sporotrichosis in Ceara, Pernambuco, Piaui, and Paraiba [13,1821]. The epidemiological investigation of sporotrichosis in endemic areas is essential to report to the public entities about the necessity of politics of prevention and control of the infection [9]. Thus, this study aimed to describe the first cases of cat-transmitted human sporotrichosis of patients seen in the reference infectious disease hospital in Natal city, Rio Grande do Norte state, Northeast Brazil.


Ethics statement

All clinical and demographic data of the patient were collected in accordance with the Local Research Ethics Committee from the Liga Norte-Riograndense Contra o Cancer Hospital, approved under number 042/042/2012. The written consent was waived because of data anonymization and commitment to preserve the identity of the patients.

Patients and sample collection

A prospective study was performed with 122 patients admitted at the Giselda Trigueiro Hospital, the infectious disease reference tertiary hospital in the Rio Grande do Norte state, Northeast Brazil, between October 2016 and December 2019. The patients were submitted to the clinical evaluation, and the type of lesions suggestive of sporotrichosis was recorded.

Clinical data were analyzed as follows: gender, age, origin, occupation, type of fungal exposure, duration, and type of lesion, body site of lesion, clinical presentation, established therapy, course of treatment, outcome of patient, and type of exposure.

The samples were collected by either punch biopsy of the skin or needle aspiration of the purulent material (inflammatory exudate) inside the nodules (both kept in saline solution for further processing). Mycological examinations were performed at the Medical and Molecular Mycology Laboratory, Clinical and Toxicological Analysis Department, Federal University of Rio Grande do Norte.

Direct examination, culture, and microculture

Biopsy fragments were carefully cut into parallel slices sections, while secretions were centrifuged at 3500 rpm for 10 minutes. Mycological direct examination of the clinical sample was performed by clarification of samples with potassium hydroxide (KOH 20%) for 30 minutes. The samples were analyzed with optical microscopy (400x of magnification). Subsequently, 20 μL aliquots of the precipitate were inoculated at seven equidistant spots on the surface of Mycosel Agar (BD, NJ, USA). The Petri dish was incubated at 25°C and observed daily for up to a month. Transition to the yeast phase was performed with further colony subculture at 37°C for another 5–10 days in brain heart infusion broth (BHI; HIMEDIA, INDIA) [7].

The macromorphological characteristics of the colonies, such as diameter, surface aspect, and melanin production, were analyzed. The micromorphological aspects, including septation, hyphal presence or absence of pigment, and type of conidiogenesis, were observed for the filamentous phase. The presence of budding cigar-shaped yeast cells was observed for yeast colonies.

Molecular identification

The isolates were cultured on Mycosel agar for seven days at 37°C, and DNA was extracted using The PrepMan Ultra Sample Preparation Reagent (Applied Biosystems), according to the manufacturer’s instructions. DNA concentration and purity were determined with a NanoDrop spectrophotometer (Thermo Fisher Scientific). Sporothrix sp. DNA was used for PCR reaction [22] using species-specific primers that targeted the calmodulin gene (CAL). Briefly, reactions were performed in a final volume of 25 μL, including 12.5 μL PCR Master Mix (Promega Corporation), consisting of 3 mM MgCl2, 400 mM each dNTPs, and 50 U/mL Taq Polymerase; 9.5 μL water, 1 μL each of forward and reverse primers (10 pmol/μL; Integrated DNA Technologies, USA), and 1 μL of target DNA [100 ng/μL]. The following primers were used: Sbra-F and Sbra-R, Ssch-F and Ssch-R, Sglo-Fand Sglo-R, Smex-F and Smex-R [22]. PCR products were size-separated by agarose gel electrophoresis, and the gel was stained in a 0.5 μg/mL ethidium bromide buffer solution (TAE) [22].

Statistics and spatial analyses

Continuous variables were expressed as mean ± standard deviation (SD) and compared using Student´s t test. Categorical variables were expressed as frequencies and percentages and compared using Chi-square (X2), as appropriate. All tests were 2-tailed, where a P-value <0.05 and a confidence interval of 95% were determined to represent statistical significance. The Spearmen coefficient was used to asses a possible correlation between age and duration of treatment. Statistical analyses were performed using the JASP software, version 0.14.10. For construction of the spatial analysis maps, we used the QGIS software, version 3.20.1.



A total of 122 patients diagnosed with subcutaneous sporotrichosis between October 2016 and December 2019 were included in the present study. Of the total, 86 corresponded to females (70.5%), representing the majority of cases. Patients’ age ranged from 5 to 87 years old with an average of 45 ± 19 years old, median of 43 years old, and mode of 34 years old. The lesions were mostly located on the upper limbs (n = 90; 73.8%), including the fingers, hand, arm and forearm; followed by the lower limbs (n = 15; 12.3%), such as foot, ankle, calf, and thigh; face, including eyelid lesions (n = 3; 2.5%), while 11.4% of them showed multiple lesions (due to multiple body sites injuries). The injury site of a single patient was not reported (Table 1).

Table 1. Demographic, clinical, mycological, and antifungal treatment data of 122 patients diagnosed with cat-transmitted subcutaneous sporotrichosis from October 2016 and December 2019 in Rio Grande do Norte, Northeast Brazil.

Regarding the clinical forms of sporotrichosis, 71 patients (58.2%) presented the lymphocutaneous form, three of them associated with erythema nodosum, four associated with polymorphic erythema, and two associated with ocular manifestation; while 48 (39.4%) had a fixed cutaneous form, with three of them presenting nodular erythema, while five patients showed polymorphic erythema. Besides these patients, patient 47 had a lymphocutaneous form, resulting from multiple cat bites on each mentioned body site: right and left arm and right calf. Patient 61 only presented polymorphic erythema, but no sporotrichoid lesions; patient 84 only had a scar on her left thigh, meaning that the lesion had started to heal after previous treatment (fixed cutaneous form). Altogether, they compose a population of 122 individuals (Table 1 and Fig 1).

Fig 1. Clinical forms of cat-transmitted subcutaneous sporotrichosis of patients seen in Rio Grande do Norte state, Northeast Brazil.

A = lymphocutaneous form. B = erythema nodosum. C = Polymorphic erythema. D = Fixed cutaneous form. E = Ulcer-crusted lesion. F = Crusted-plaque lesion. G = Sporotrichotic rosary. H = Reactive arthritis (arthralgia). I = Conjunctival infiltrate.

In addition, three patients had a hypersensitivity reaction related to the lesion site. Atypical lesions were also observed in 4 patients, where two of them had an ulcer-crusted lesion (27 and 114) while the other two had a lesion in the form of a crusted plaque (58 and 113); and two patients (56 and 92) showed the sign of the sporotrichotic rosary. In addition, patients 19 and 47 had arthralgias, and patients 20 and 43 showed conjunctival infiltrate (Table 1 and Fig 1). No statistically significant correlation was observed for either the clinical form versus sex or clinical form versus age of patients (P˃0.05).

Epidemiological data

The patients had different occupations, but 31 female patients were involved with domestic activities. Of the 122 patients, 115 (94.3%) reported previous contact with cats, either at work or at home. Among the total, 25 patients (21.7%) did not report any type of injury; 63 (54.8%) reported scratching by a cat; 18 (15.7%) reported bite, and nine cases (7.8%) reported both bite and scratch. In addition, one patient reported a glass injury (with remaining cat blood) that had previously cut an infected cat (diagnosed with sporotrichosis), and a single patient reported a barbed-wire fence injury. The time between the exposure and the appearance of the first sporotrichosis lesions lasted an average of 22 ± 18 days, with a median of 15 days and a 14-day mode, ranging from 2 to 90 days.

All the clinical cases occurred in urban areas, 98 (80.3%) patients lived in the city of Natal, Rio Grande do Norte state, Brazil. Among these, 45 cases (45.9%) occurred in the West Zone, with the highest concentration in the Quintas district (17 cases), followed by 17 cases in the South Zone (27.6%), 20 cases in the North Zone (20.4%) and six in the East Zone (6.1%). In addition, 23 cases (18.8%) occurred in neighboring municipalities (metropolitan region of Natal; Fig 2A and 2B). The address information is missing for a single patient.

Fig 2.

Spatial distribution of cat-transmitted sporotrichosis in Rio Grande do Norte state, Northeast Brazil from October 2016 to December 2019 (A). The most affected area is Quintas district, in the West Zone of the metropolitan region of Natal (B).

Phenotypic and molecular identification

Of the 122 cases, 71 (58.2%) of them were only clinically diagnosed (no mycological examination and PCR were performed), while 51 (41.8%) patients had a mycological examination, with the recovery of the etiological agent in culture and further PCR confirmation of the species involved. The phenotypic analysis, through the observation of macro and micromorphological characteristics, allowed the identification of the isolates at the genus level, being all initially identified as Sporothrix sp. For accurate identification at the species level, all isolates were subjected to molecular analysis. After PCR reaction and subsequent electrophoresis, a 469 bp DNA fragment product was observed using primers Sbra-F and Sbra-R, leading to the identification of 50 strains as S. brasiliensis, whereas a single sample showed no PCR amplification (patient 114, who reported barbed-wire injury).


One hundred and eighteen patients (96.7%) received an oral itraconazole treatment regimen, with daily doses of 200 mg; three of them were treated with saturated potassium iodide solution using 10 oral drops daily, and patient 77 presented spontaneous regression, using itraconazole for only 7 days. The treatment performed with itraconazole had an average duration of 12 ± 3.5 weeks, mode and median of 13 weeks, ranging from four to 25 weeks. The treatment carried out with potassium iodide was used for three patients, with an average of 9 ± 3 weeks ranging from 7 to 13 weeks. However, the length of treatment for 9 patients was missed during the study (Table 1).

The length of treatment was not influenced by the patient´s age or sex (P˃0.05). However, the most prolonged period of treatment (25 weeks) was necessary for a male patient aged 58 years old (56), and the shortest treatment length (4 weeks) was presented by four patients, 2 males aged 34 (patients 78 and 87) and another one who was 37 years old (patient 82), and a female patient aged 17 years old (patient 59). Nevertheless, when we have analyzed the length of treatment with itraconazole for each clinical form separately, it was possible to observe a statistically significant shorter period of time needed to treat patients with the fixed cutaneous form (duration of 11 ± 3.3 weeks, mode of 11.5 and median of 13 weeks, ranging from 4 to 19 weeks) when compared to those with lymphocutaneous lesions (duration of 12 ± 3. weeks, mode and median of 13 weeks, ranging from 1 to 25 weeks; P = 0.03).

In addition, 5 patients needed dose adjustment for itraconazole as follows: patient 38 who needed an increase in itraconazole dose from 200 mg/daily to 400 mg/daily after 7 weeks of treatment; patients 111 and 114 who started using 300 mg/daily after 2 weeks of treatment; and patients 101 and 108 who had their doses adjusted to 300 mg/daily of itraconazole after 5 and 4 weeks, respectively.


We describe here clinical case series of 122 cat-transmitted subcutaneous sporotrichosis mainly due to S. brasiliensis in Northeast Brazil. All the strains (except the strain obtained from patient 144) recovered from mycological cultures belong to this species, following the same trend of studies regarding zoonotic sporotrichosis performed in Brazil. It is important to note that S. brasiliensis was restricted to the South and Southeast of Brazil until mid-2010 [23]. Other Sporothrix spp., mainly S. schenckii sensu stricto, have been less related to transmission by cats in a few countries, including the United States, India, Malaysia, Argentina, Mexico, and Panama [17]. Another molecular technique with a better discriminatory power (such as rDNA sequencing) is mandatory to identify the strain obtained from patient 144 accurately. He reported injury when trying to go through a barbed-wire fence. We cannot rule out the possibility that S. chilensis [24] is the etiological agent of this case because this species has been recently described in 4 cases of sporotrichosis in the same Brazilian region (Northeast) of the present study [18].

Pubmed searches using the terms “Sporothrix brasiliensis” and “sporotrichosis cases” only retrieved 42 results. It is worth mentioning that most of these publications are rather related to feline sporotrichosis itself or even to basic sciences investigations regarding S. brasiliensis virulence. To the best of our knowledge, this is the first case series with a high number of patients seen in an area spanning nearly 2,700 km of distance from the epicenter in Rio de Janeiro, showing the spreading of the epidemic in other parts of Brazil (Northeast region).

Gremião et al. [25] reported the expansion of cat-transmitted sporotrichosis in Brazil. Rio de Janeiro researchers have been publishing high frequent emergent human cases of zoonotic transmission sporotrichosis since the late nineties [26], with almost 5,000 cases recorded from 1997 to 2011 [27]. However, since 1998, Brazil is under the geographic expansion of zoonotic sporotrichosis toward different regions of this continental-size country [26].

Cases of human sporotrichosis have been reported in almost all the 26 Brazilian states, but those directly related to cat transmission due to S. brasiliensis are highly concentered within Southwest and South regions [8], such as Sao Paulo [28], Espirito Santo [29] and Minas Gerais [30]. Recently, a case series of human zoonotic sporotrichosis has been described in Brasilia (Federal District; Midwestern Region) [31]. Only three other publications from the same region of the present study were found, two of them from Pernambuco state [18,32] and a case report of primary pulmonary sporotrichosis in an apparently immunocompetent female patient published by our group [7]. Apart from Brazil, cat-transmitted sporotrichosis was only reported recently in the North area of Buenos Aires province, Argentina, specifically in rural areas. Small outbreaks have been reported involving felines, cat owners, and even a veterinary doctor who examined a sick cat [33], proving that the spreading of the epidemic is already happening in South America. Since then, 21 cases of human sporotrichosis and 24 of feline sporotrichosis have been reported in the literature, reaching unprecedented levels, with a four-fold increase of cases of S. brasiliensis infections in humans from 2011 to 2019 [34].

Female patients were the vast majority of individuals found in our study. This finding is thought to be related to the high number of women who work as housewives or cleaners in Brazil and are in closest contact with animals at home. Similar results were obtained by other authors who investigated cat-transmitted sporotrichosis [35,36].

The upper limb was the most frequent body site found in the present study, followed by the lower limb and face. It is worth mentioning that these body sites are the most frequently affected, according to different studies [11]. Face lesions are described as more often observed in children and adolescents [37], corroborating with our results. Lymphocutaneous and fixed cutaneous clinical forms were found in our study. In cutaneous forms, the infection happens after injury with epidermis disruption. After fungal conversion into the host body, yeast cells may remain localized in host tissues (fixed forms) or disseminate to adjacent lymphatic vessels in the case of lymphocutaneous form. More rarely, where there is hematogenous dissemination, the cutaneous-disseminated form is found [11].

The fact that 39.4% of our patients had the fixed form is an unusual finding. Some authors believe that continuous exposure to small amounts of conidia could gradually confer immunity, specifically in patients with previous Sporothrix spp. traumatic inoculation preventing dissemination through the lymphatic system [38]. Nevertheless, in a study conducted in Iran, where sporotrichosis is a rare clinical condition, 7 out of 9 patients had the fixed cutaneous clinical form. These results suggest that this clinical form may be predominant in some regions of the globe [39].

Erythema nodosum in patients with cat-transmitted sporotrichosis was firstly reported by Galhardo et al., 2002 [40]. It has been considered a clinical syndrome possibly related to a hypersensitivity reaction due to inflammatory infection, neoplasm, and medication’s adverse effect. It is an acute eruption of erythematous nodules in lower limbs that may be followed by fever, malaise, and arthralgia. Erythema multiforme has also been previously described in zoonotic sporotrichosis. It is recognized as a vesiculobullous disorder with variable manifestations in the skin and is also considered a hypersensitivity disease [41].

Interestingly, we also had a 45-years-old female patient who used to treat a sick cat diagnosed with sporotrichosis. She denied bits and scratches and reported pain in her itchy and watery right eye which started 8 days after the appearance of subcutaneous sporotrichoid lesions in her left forearm. Schubach et al., 2005 [42] reported two cases of female patients presenting conjunctival granulomatous lesions with hyperemia, secretion, and edema. The authors reinforce the fact that conjunctival lesions are rarely observed in patients with sporotrichosis. In a study with 566 patients with sporotrichosis, only 13 (2.3% of them) had conjunctival lesions [42]. Because ocular manifestations of sporotrichosis are usually caused either by traumatic injury or due to hematogenous dissemination [43], only very few cases of primary granulomatous conjunctivitis have been reported in the literature [36,44,45].

Another interesting finding is that more than 36% of patients used to live in Natal city West Zone. This is also the region of the city with the highest number of cases with feline sporotrichosis. In fact, the veterinary doctors claim that this is the epicenter of feline and human sporotrichosis in Natal city. The first human and feline cases found at the beginning of the outbreak were described there. We hypothesize that this finding is due to the fact that this is one of the lowest income regions of the city, where cat owners usually do not have economic conditions to treat their animals. In addition, houses are divided by the same walls, which may favor feral and domestic cats contact and fights.

The fact that S. brasiliensis cells are already in the yeast form even colonizing cat´s claws and oral cavities may somehow favor the human infection because the fungus is well adapted to a warmblood animal, instead of the usual filamentous forms found in the environment, where temperatures are usually bellow 30°C. Therefore, conversion to the parasitic phase is not necessary when it reaches the human host [46,47]. In addition, it has been shown that S. brasiliensis can form biofilms on cat claws, which can lead to greater fungus persistence and better transmission during traumatic inoculation [48]. In addition, quite a few investigations reported S. brasiliensis as more virulent than S. schenckii sensu stricto. This fact may have influenced the spreading of cat-transmitted sporotrichosis in our continental-size country [4951].

Finally, our patients were successfully treated with itraconazole, and therapeutic cure was observed in 100% of them. The most common antifungal drug to treat the patients was itraconazole. This is considered the drug of choice to treat subcutaneous sporotrichosis [52]. Interestingly, the treatment performed with this antifungal drug had a median duration of 13 weeks, 3 weeks before than what was observed by Almeida-Paes et al. [36]. This finding may be related to the doses used in the present study (200 mg/daily) instead of 100 mg/daily reported by these authors. Important to note dose adjustments and spontaneous regressions of sporotrichosis have also been observed in the present study.

Our study reported 122 cases of subcutaneous sporotrichosis in Northeast Brazil. One hundred and fifteen of them reported cat transmission. Diagnosis PCR revealed that 71 of them were due to S. brasiliensis. The majority of patients were female (70.5%). Patient’s age ranged from five to 87 years old. Most patients had the lymphocutaneous form (58.2%), but a relatively high percentage was found for the fixed cutaneous form (39.4%). Patients were successfully treated with itraconazole and potassium iodide. A limitation of our study is that in quite a few occasions, the diagnosis of zoonotic sporotrichosis was only clinical and not based on mycological examination and further identification with molecular biology methods. We are currently working on virulence factors expression and antifungal susceptibility testing of these isolates. Our findings are very similar to other publications of different Brazilian states reinforcing the idea of an epidemic and outbreak of feline sporotrichosis are underway in Brazil and Argentina, highlighting the spreading of the Disease toward South America.


We are very grateful to Maria José Pieretti, PharmD., for the management of treatment of patients with subcutaneous sporotrichosis enrolled in the present study.


  1. 1. Garcia Carnero LC, Lozoya Perez NE, Gonzalez Hernandez SE, Martinez Alvarez JA. Immunity and Treatment of Sporotrichosis. J Fungi (Basel). 2018;4(3). Epub 2018/08/22. jof4030100 [pii] pmid:30127270; PubMed Central PMCID: PMC6162376.
  2. 2. Conceicao-Silva F, Morgado FN. Immunopathogenesis of Human Sporotrichosis: What We Already Know. J Fungi (Basel). 2018;4(3). Epub 2018/08/02. jof4030089 [pii] pmid:30065160; PubMed Central PMCID: PMC6162489.
  3. 3. Estrada-Castanon R, Chavez-Lopez G, Estrada-Chavez G, Bonifaz A. Report of 73 cases of cutaneous sporotrichosis in Mexico. An Bras Dermatol. 2018;93(6):907–9. Epub 2018/11/30. S0365-05962018000600907 [pii] pmid:30484544; PubMed Central PMCID: PMC6256232.
  4. 4. Mialski R, de Oliveira JN Jr., da Silva LH, Kono A, Pinheiro RL, Teixeira MJ, et al. Chronic Meningitis and Hydrocephalus due to Sporothrix brasiliensis in Immunocompetent Adults: A Challenging Entity. Open Forum Infect Dis. 2018;5(5):ofy081. Epub 2018/07/07. ofy081 [pii]. pmid:29977951; PubMed Central PMCID: PMC6007373.
  5. 5. Yagnik KJ, Skelton WPt, Olson A, Trillo CA, Lascano J. A rare case of disseminated Sporothrix schenckii with bone marrow involvement in a patient with idiopathic CD4 lymphocytopenia. IDCases. 2017;9:70–2. Epub 2017/07/15. S2214-2509(17)30096-3 [pii]. pmid:28706855; PubMed Central PMCID: PMC5503829.
  6. 6. Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment and outcome. Medicine (Baltimore). 1986;65(3):143–53. Epub 1986/05/01. pmid:3517551.
  7. 7. do Monte Alves M, Pipolo Milan E, da Silva-Rocha WP, Soares de Sena da Costa A, Araujo Maciel B, Cavalcante Vale PH, et al. Fatal pulmonary sporotrichosis caused by Sporothrix brasiliensis in Northeast Brazil. PLoS Negl Trop Dis. 2020;14(5):e0008141. Epub 2020/05/27. pmid:32453723; PubMed Central PMCID: PMC7274469.
  8. 8. Rodrigues AM, de Melo Teixeira M, de Hoog GS, Schubach TM, Pereira SA, Fernandes GF, et al. Phylogenetic analysis reveals a high prevalence of Sporothrix brasiliensis in feline sporotrichosis outbreaks. PLoS Negl Trop Dis. 2013;7(6):e2281. Epub 2013/07/03. PNTD-D-13-00352 [pii]. pmid:23818999; PubMed Central PMCID: PMC3688539.
  9. 9. Poester VR, Mattei AS, Madrid IM, Pereira JTB, Klafke GB, Sanchotene KO, et al. Sporotrichosis in Southern Brazil, towards an epidemic? Zoonoses Public Health. 2018;65(7):815–21. Epub 2018/07/17. pmid:30009528.
  10. 10. Cordoba S, Isla G, Szusz W, Vivot W, Hevia A, Davel G, et al. Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina. Mycoses. 2018;61(7):441–8. Epub 2018/03/04. pmid:29500853.
  11. 11. Barros MB, de Almeida Paes R, Schubach AO. Sporothrix schenckii and sporotrichosis. Clin Microbiol Rev. 2011;24(4):633–54. pmid:21976602; PubMed Central PMCID: PMC3194828.
  12. 12. Marimon R, Cano J, Gene J, Sutton DA, Kawasaki M, Guarro J. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol. 2007;45(10):3198–206. Epub 2007/08/10. JCM.00808-07 [pii] pmid:17687013; PubMed Central PMCID: PMC2045377.
  13. 13. Rodrigues AM, de Hoog GS, de Camargo ZP. Sporothrix Species Causing Outbreaks in Animals and Humans Driven by Animal-Animal Transmission. PLoS Pathog. 2016;12(7):e1005638. Epub 2016/07/16. pmid:27415796; PubMed Central PMCID: PMC4945023.
  14. 14. de Beer ZW, Duong TA, Wingfield MJ. The divorce of Sporothrix and Ophiostoma: solution to a problematic relationship. Stud Mycol. 2016;83:165–91. Epub 2016/09/13. pmid:27616802; PubMed Central PMCID: PMC5007658.
  15. 15. Rodrigues AM, Cruz Choappa R, Fernandes GF, de Hoog GS, de Camargo ZP. Sporothrix chilensis sp. nov. (Ascomycota: Ophiostomatales), a soil-borne agent of human sporotrichosis with mild-pathogenic potential to mammals. Fungal Biol. 2016;120(2):246–64. Epub 2016/01/20. pmid:26781380.
  16. 16. Gutierrez-Galhardo MC, Freitas DFS, do Valle ACF, Almeida-Paes R, de Oliveira MME, Zancopé-Oliveira RM. Epidemiological Aspects of Sporotrichosis Epidemic in Brazil. Current Fungal Infection Reports. 2015;9(4):238–45.
  17. 17. Gremiao ID, Miranda LH, Reis EG, Rodrigues AM, Pereira SA. Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission. PLoS Pathog. 2017;13(1):e1006077. Epub 2017/01/20. PPATHOGENS-D-16-01061 [pii]. pmid:28103311; PubMed Central PMCID: PMC5245785.
  18. 18. Valeriano CAT, Ferraz CE, Oliveira MME, Inacio CP, de Oliveira EP, Lacerda AM, et al. Cat-transmitted disseminated cutaneous sporotrichosis caused by Sporothrix brasiliensis in a new endemic area: Case series in the northeast of Brazil. JAAD Case Rep. 2020;6(10):988–92. Epub 2020/10/01. pmid:32995426; PubMed Central PMCID: PMC7508904.
  19. 19. Filgueira KD. Sporotrichosis in the canine species: a case report on city of Mossoro, RN. Cieência Animal Brasileira. 2009;10(2):673–7.
  20. 20. Nunes GDL, dos Santos Carneiro R, Filgueira KD, Filgueira FGF, Fernandes THT. Feline sporotrichosis in Itaporanga municipality, Paraíba state, Brazil: case report Arquivos de Ciências Veterinárias e Zoologia da UNIPAR 2011;14(2).
  21. 21. Araujo AKL, de Santana Leal CA. Feline sporotrichosis in the municipality of Bezerros, Agreste Pernambucano: case report. Pubvet. 2016;10:795–872.
  22. 22. Rodrigues AM, de Hoog GS, de Camargo ZP. Molecular Diagnosis of Pathogenic Sporothrix Species. PLoS Negl Trop Dis. 2015;9(12):e0004190. Epub 2015/12/02. PNTD-D-15-01284 [pii]. pmid:26623643; PubMed Central PMCID: PMC4666615.
  23. 23. Rodrigues AM, Della Terra PP, Gremiao ID, Pereira SA, Orofino-Costa R, de Camargo ZP. The threat of emerging and re-emerging pathogenic Sporothrix species. Mycopathologia. 2020;185(5):813–42. Epub 2020/02/14. pmid:32052359.
  24. 24. Valeriano CAT, Lima-Neto RG, Inacio CP, Rabello VBS, Oliveira EP, Zancope-Oliveira RM, et al. Is Sporothrix chilensis circulating outside Chile? PLoS Negl Trop Dis. 2020;14(3):e0008151. Epub 2020/04/01. pmid:32226021; PubMed Central PMCID: PMC7162539.
  25. 25. Gremiao IDF, Oliveira MME, Monteiro de Miranda LH, Saraiva Freitas DF, Pereira SA. Geographic Expansion of Sporotrichosis, Brazil. Emerg Infect Dis. 2020;26(3):621–4. Epub 2020/02/25. pmid:32091376; PubMed Central PMCID: PMC7045854.
  26. 26. Lopes-Bezerra LM, Mora-Montes HM, Zhang Y, Nino-Vega G, Rodrigues AM, de Camargo ZP, et al. Sporotrichosis between 1898 and 2017: The evolution of knowledge on a changeable disease and on emerging etiological agents. Med Mycol. 2018;56(suppl_1):126–43. Epub 2018/03/15. pmid:29538731.
  27. 27. Silva MB, Costa MM, Torres CC, Galhardo MC, Valle AC, Magalhães MA, et al. Urban sporotrichosis: a neglected epidemic in Rio de Janeiro, Brazil Caderno de Saude Publica 2012;28(10):1867–80. pmid:23090167
  28. 28. Fleury RN, Taborda PR, Gupta AK, Fujita MS, Rosa PS, Weckwerth AC, et al. Zoonotic sporotrichosis. Transmission to humans by infected domestic cat scratching: report of four cases in Sao Paulo, Brazil. Int J Dermatol. 2001;40(5):318–22. Epub 2001/09/29. pmid:11575308.
  29. 29. de Araujo ML, Rodrigues AM, Fernandes GF, de Camargo ZP, de Hoog GS. Human sporotrichosis beyond the epidemic front reveals classical transmission types in Espirito Santo, Brazil. Mycoses. 2015;58(8):485–90. Epub 2015/07/15. pmid:26156862.
  30. 30. Paiva MT, de Oliveira CSF, Nicolino RR, Bastos CV, Lecca LO, de Azevedo MI, et al. Spatial association between sporotrichosis in cats and in human during a Brazilian epidemics. Prev Vet Med. 2020;183:105125. Epub 2020/09/07. pmid:32891900.
  31. 31. Eudes Filho J, Santos IBD, Reis CMS, Patane JSL, Paredes V, Bernardes J, et al. A novel Sporothrix brasiliensis genomic variant in Midwestern Brazil: evidence for an older and wider sporotrichosis epidemic. Emerg Microbes Infect. 2020;9(1):2515–25. Epub 2020/11/07. pmid:33155518; PubMed Central PMCID: PMC7717857.
  32. 32. Lacerda Filho AM, Cavalcante CM, Da Silva AB, Inacio CP, de Lima-Neto RG, de Andrade MCL, et al. High-Virulence Cat-Transmitted Ocular Sporotrichosis. Mycopathologia. 2019;184(4):547–9. Epub 2019/06/24. pmid:31230198.
  33. 33. Etchecopaz A, Scarpa M, Mas J, Cuestas ML. Sporothrix brasiliensis: A growing hazard in the Northern area of Buenos Aires Province? Rev Argent Microbiol. 2020;52(4):350–1. Epub 2020/03/21. pmid:32192862.
  34. 34. Etchecopaz A, Toscanini MA, Gisbert A, Mas J, Scarpa M, Iovannitti CA, et al. Sporothrix Brasiliensis: A Review of an Emerging South American Fungal Pathogen, Its Related Disease, Presentation and Spread in Argentina. J Fungi (Basel). 2021;7(3). Epub 2021/03/04. pmid:33652625; PubMed Central PMCID: PMC7996880.
  35. 35. Schubach A, Barros MB, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis. 2008;21(2):129–33. Epub 2008/03/05. pmid:18317034.
  36. 36. Almeida-Paes R, de Oliveira MM, Freitas DF, do Valle AC, Zancope-Oliveira RM, Gutierrez-Galhardo MC. Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis is associated with atypical clinical presentations. PLoS Negl Trop Dis. 2014;8(9):e3094. pmid:25233227; PubMed Central PMCID: PMC4169245.
  37. 37. Tlougan BE, Podjasek JO, Patel SP, Nguyen XH, Hansen RC. Neonatal sporotrichosis. Pediatr Dermatol. 2009;26(5):563–5. Epub 2009/10/21. pmid:19840311.
  38. 38. Lavalle P, Mariat F. Sporotrichosis. Bull Inst Pasteur 1983;81:295–322.
  39. 39. Mahmoudi S, Zaini F. Sporotrichosis in Iran: A mini review of reported cases in patients suspected to cutaneous leishmaniasis. Curr Med Mycol. 2015;1(2):39–45. Epub 2015/06/01. pmid:28680987; PubMed Central PMCID: PMC5490312.
  40. 40. Gutierrez Galhardo MC, de Oliveira Schubach A, de Lima Barros MB, Moita Blanco TC, Cuzzi-Maya T, Pacheco Schubach TM, et al. Erythema nodosum associated with sporotrichosis. Int J Dermatol. 2002;41(2):114–6. Epub 2002/05/02. pmid:11982651.
  41. 41. Gutierrez-Galhardo MC, Barros MB, Schubach AO, Cuzzi T, Schubach TM, Lazera MS, et al. Erythema multiforme associated with sporotrichosis. J Eur Acad Dermatol Venereol. 2005;19(4):507–9. Epub 2005/07/01. pmid:15987308.
  42. 42. Schubach A, de Lima Barros MB, Schubach TM, Francesconi-do-Valle AC, Gutierrez-Galhardo MC, Sued M, et al. Primary conjunctival sporotrichosis: two cases from a zoonotic epidemic in Rio de Janeiro, Brazil. Cornea. 2005;24(4):491–3. Epub 2005/04/15. pmid:15829813.
  43. 43. Curi AL, Felix S, Azevedo KM, Estrela R, Villar EG, Saraca G. Retinal granuloma caused by Sporothrix schenckii. Am J Ophthalmol. 2003;136(1):205–7. Epub 2003/07/02. pmid:12834701.
  44. 44. Gordon DM. Ocular sporotrichosis; report of a case. Arch Ophthal. 1947;37(1):56–72. Epub 1947/01/01. pmid:20285742.
  45. 45. Alvarez R, Lopez-Villegas A. Primary ocular sporotrichosis. Am J Ophthalmol. 1966;62(1):150–1. Epub 1966/07/01. pmid:5937147.
  46. 46. Barros MB, Schubach AO, Schubach TM, Wanke B, Lambert-Passos SR. An epidemic of sporotrichosis in Rio de Janeiro, Brazil: epidemiological aspects of a series of cases. Epidemiol Infect. 2008;136(9):1192–6. Epub 2007/11/22. pmid:18028580; PubMed Central PMCID: PMC2870916.
  47. 47. Schubach TM, Valle AC, Gutierrez-Galhardo MC, Monteiro PC, Reis RS, Zancope-Oliveira RM, et al. Isolation of Sporothrix schenckii from the nails of domestic cats (Felis catus). Med Mycol. 2001;39(1):147–9. Epub 2001/03/29. pmid:11270404.
  48. 48. Brilhante RSN, Fernandes MR, Pereira VS, Costa ADC, Oliveira JS, de Aguiar L, et al. Biofilm formation on cat claws by Sporothrix species: An ex vivo model. Microb Pathog. 2021;150:104670. Epub 2020/12/08. pmid:33285221.
  49. 49. Batista-Duharte A, Tellez-Martinez D, Roberto de Andrade C, Portuondo DL, Jellmayer JA, Polesi MC, et al. Sporothrix brasiliensis induces a more severe disease associated with sustained Th17 and regulatory T cells responses than Sporothrix schenckii sensu stricto in mice. Fungal Biol. 2018;122(12):1163–70. Epub 2018/11/20. S1878-6146(18)30222-8 [pii] pmid:30449354.
  50. 50. Della Terra PP, Rodrigues AM, Fernandes GF, Nishikaku AS, Burger E, de Camargo ZP. Exploring virulence and immunogenicity in the emerging pathogen Sporothrix brasiliensis. PLoS Negl Trop Dis. 2017;11(8):e0005903. Epub 2017/08/31. pmid:28854184; PubMed Central PMCID: PMC5595342.
  51. 51. Fernandes GF, dos Santos PO, Rodrigues AM, Sasaki AA, Burger E, de Camargo ZP. Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species. Virulence. 2013;4(3):241–9. Epub 2013/01/18. pmid:23324498; PubMed Central PMCID: PMC3711982.
  52. 52. de Lima Barros MB, Schubach AO, de Vasconcellos Carvalhaes de Oliveira R, Martins EB, Teixeira JL, Wanke B. Treatment of cutaneous sporotrichosis with itraconazole—study of 645 patients. Clin Infect Dis. 2011;52(12):e200–6. Epub 2011/06/02. pmid:21628477.